Strong support from pharma groups including Amgen, Bristol Myers Squibb and Pfizer has allowed European venture capital firm Sofinnova Partners to close a new biotech fund with €165 million ($180 ...

With decades of experience in pharmaceutical development and extensive genetic medicine expertise, Doug E. Williams, Ph.D., and Murray Stewart, DM FRCP, will provide strategic guidance for CAMP4’s ...

If left unchecked, the power of PBMs and their complex relationships within the American healthcare system could lead to higher drug costs and diminished returns.

On the purchasing front, ARK showed a clear vote of confidence in Iridium Communications Inc (NASDAQ: IRDM ), amassing a total of 121,941 shares across three of its ETFs—ARKK, ARKQ, and ARKX—for a ...